Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,727 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,611 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00092924 | Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | — | Human Genome Sciences Inc.INDUSTRY | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00585533 | A Phase 2 Study of Tarceva for Untreated, Good Prognosis Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 40 | University of UtahOTHER | 1 | Jul 30, 2013 | clinicaltrials |
| NCT00805077 | Pulmonary Surgery and Protective Mechanical Ventilation(VPP) | completed | N/A | 347 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 29, 2013 | clinicaltrials |
| NCT00003111 | Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer | completed | Phase 2 | 10 | Yale UniversityOTHER | 1 | Jul 25, 2013 | clinicaltrials |
| NCT00039052 | Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer | completed | Phase 1 | — | Neurocrine BiosciencesINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00072059 | Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00079235 | CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Jul 16, 2013 | clinicaltrials |
| NCT00702975 | Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic Therapy | completed | Phase 2 | 35 | Radboud University Medical CenterOTHER | 1 | Jul 15, 2013 | clinicaltrials |
| NCT00463515 | Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC(CHER@NOS) | completed | Phase 2 | 77 | University Hospital, AntwerpOTHER | 1 | Jul 12, 2013 | clinicaltrials |
| NCT00022711 | Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer | completed | Phase 2 | 7 | Fox Chase Cancer CenterOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00796796 | Temsirolimus and Radiation for Non-Small Cell Lung Cancer | completed | Phase 1 | 10 | Washington University School of MedicineOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00002475 | Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | completed | Phase 2 | 40 | St. Vincent Medical Center - Los AngelesOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00003089 | Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer | completed | Phase 2 | — | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00005091 | DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | completed | Phase 2 | — | Daiichi PharmaceuticalsINDUSTRY | 5 | Jul 10, 2013 | clinicaltrials |
| NCT00529100 | Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 49 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 9, 2013 | clinicaltrials |
| NCT00002852 | Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer | completed | Phase 3 | 500 | National Cancer Institute (NCI)NIH | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00003022 | Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00771563 | Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES)(SYRINGES) | completed | Phase 3 | 104 | University Hospital, AntwerpOTHER | 1 | Jun 28, 2013 | clinicaltrials |
| NCT01038492 | p16 Methylation for Smoking Cessation | completed | N/A | 35 | Duke UniversityOTHER | 1 | Jun 28, 2013 | clinicaltrials |
| NCT00003037 | Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | completed | Phase 1 / Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 27, 2013 | clinicaltrials |
| NCT00008255 | INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00036920 | TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00062283 | Alanosine in Treating Patients With Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00600587 | Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 24 | Guangdong Provincial People's HospitalOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00004065 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00006019 | Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00006484 | Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | completed | Phase 3 | — | SWOG Cancer Research NetworkNETWORK | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00068289 | Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy | completed | Phase 2 | — | SWOG Cancer Research NetworkNETWORK | 2 | Jun 24, 2013 | clinicaltrials |
| NCT00003881 | Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | — | Eastern Cooperative Oncology GroupNETWORK | 3 | Jun 21, 2013 | clinicaltrials |
| NCT00047736 | A Study With Tarceva and Chemotherapy vs. Chemotherapy Alone in Patients With Advanced Lung Cancer | completed | Phase 3 | — | Genentech, Inc.INDUSTRY | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00019084 | Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019331 | Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019929 | Vaccine Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00091039 | Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With Surgery | completed | N/A | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00635791 | Phase I Study of Vorinostat and Sorafenib in Advanced Cancer | completed | Phase 1 | 36 | University of Colorado, DenverOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00871403 | Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 107 | GlaxoSmithKlineINDUSTRY | 2 | Jun 20, 2013 | clinicaltrials |
| NCT00004238 | 10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00004249 | Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00004930 | Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00005630 | Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00005806 | Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00452634 | Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC) | completed | Phase 2 | 62 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00620347 | Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung Cancer | completed | Phase 2 | 25 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00027638 | Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00433602 | Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors | completed | — | 64 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jun 12, 2013 | clinicaltrials |
| NCT00536640 | Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabine/Cisplatin Plus Bevacizumab(INNOVATIONS) | completed | Phase 2 | 224 | Aktion Bronchialkarzinom e.V.OTHER | 1 | Jun 12, 2013 | clinicaltrials |
| NCT00062101 | Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Jun 6, 2013 | clinicaltrials |
| NCT00040794 | Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer | completed | Phase 2 | 144 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00081107 | Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 5, 2013 | clinicaltrials |
Data updated 24 days agoSource updated Aug 2, 2013source: clinicaltrials